Is STSA or RYLD a better dividend investment in 2026?

STSA currently yields 136.36% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: STSA offers higher current income.

What is the dividend yield difference between STSA and RYLD?

STSA has a forward dividend yield of 136.36% ($1.50/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 123.97 percentage points.

Home › Compare › STSA vs RYLD

STSA vs RYLD: Dividend Comparison 2026

STSA yields 136.36% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 STSA wins by $15.52M in total portfolio value

INVESTMENT

TIME HORIZON10 years

STSA

● Live price

136.36%

Share price

$1.10

Annual div

$1.50

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$15.56M

Annual income

$6,371,447.45

Full STSA calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — STSA vs RYLD

📍 STSA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	STSA	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, STSA + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

STSA pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STSA

Annual income on $10K today (after 15% tax)

$11,590.91/yr

After 10yr DRIP, annual income (after tax)

$5,415,730.33/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, STSA beats the other by $5,413,449.80/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STSA + RYLD for your $10,000?

STSA: 50%RYLD: 50%

100% RYLD50/50100% STSA

Portfolio after 10yr

$7.80M

Annual income

$3,187,065.21/yr

Blended yield

40.84%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on STSA right now

STSA

Analyst Ratings

Buy

Hold

Consensus: Hold

Altman Z

-7.4

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STSA buys

RYLD buys

No recent congressional trades found for STSA or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSTSARYLD

Forward yield	136.36% ✓	12.39%
Annual dividend / share	$1.50	$1.81 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$15.56M	$45.3K ✓
Annual income after 10y	$6,371,447.45 ✓	$2,682.98
Total dividends collected	$14.30M	$19.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: STSA vs RYLD ($10,000, DRIP)

Year	STSA Portfolio	STSA Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$24,336	$13,636.36	$11,939	$1,239.34	+$12.4K → STSA
2	$57,055	$31,014.91	$14,158	$1,382.89	+$42.9K → STSA
3	$129,004	$67,955.30	$16,682	$1,532.59	+$112.3K → STSA
4	$281,633	$143,598.62	$19,537	$1,687.64	+$262.1K → STSA
5	$594,333	$292,985.93	$22,752	$1,847.20	+$571.6K → STSA
6	$1,213,779	$577,842.64	$26,355	$2,010.43	+$1.19M → STSA
7	$2,401,642	$1,102,898.48	$30,376	$2,176.45	+$2.37M → STSA
8	$4,609,241	$2,039,484.49	$34,847	$2,344.43	+$4.57M → STSA
9	$8,590,007	$3,658,118.87	$39,800	$2,513.54	+$8.55M → STSA
10	$15,562,755	$6,371,447.45	$45,269	$2,682.98	+$15.52M → STSA

STSA vs RYLD: Complete Analysis 2026

STSA — Stock

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Full STSA Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this STSA vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STSA vs SCHD STSA vs JEPI STSA vs O STSA vs KO STSA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.